Paul Reckwerdt
TomoTherapy

>> Next Bio

Mr. Reckwerdt has been working for the past two decades in physics related product development and research and is currently the President and Founder of TomoTherapy Incorporated, a company selling a novel system for advanced cancer treatments.

Besides being one of the originators and inventors of the TomoTherapy concept, he has guided the company through five successful rounds of investments and the global launch of the Hi-ART system. Starting with seven people in 1999 he continues to build the global infrastructure of the company which currently has over 500 employees and installations around the world. Although most of his time is used in managing the expansive growth of TomoTherapy he is still active in the continued scientific development of the system’s capabilities.

Besides TomoTherapy his work includes years of private industrial experience, involving analysis, design, and implementation of heavy ion and other particle acceleration systems. 

 His early research at the University of Wisconsin included implementation and analysis of clinical studies into Parkinson disease, ALS, dementia, and epilepsy. Later research in cancer therapy has lead into his recent commercial endeavors.

 In 1992 he co-founded Geometrics Corporation a software application company in Madison, Wisconsin that created the world’s first real 3D radiation treatment planning system used for cancer treatments. This software became the leading RTP system sold for many years. This company was sold in 1996 to ADAC laboratories now a division of Phillips International.

The author or co-author of over 25 peer reviewed papers and presentations, Mr. Reckwerdt is also the recipient of the Farrington Daniels Award in Medical Physics and the Ernst and Young Entrepreneur of the Year award.